Initial antihypertensive therapy: What are the current drugs of choice?

Postgraduate Medicine

Volumn 110, Issue 5, 2001, Pages 39-54

  Yeun, J Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN MESYLATE; ENALAPRIL; FELODIPINE; HYDROCHLOROTHIAZIDE; ISRADIPINE; LISINOPRIL; METOPROLOL; NITRENDIPINE; PINDOLOL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; HEALTH CARE COST; HUMAN; HYPERTENSION; PRACTICE GUIDELINE; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0035171189     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.1080/00325481.2001.11445494     Document Type: Conference Paper

References (14)

1. Health outcomes associated with antihypertensive therapies used as first-line agents: A systematic review and meta-analysis
2. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
3. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
4. Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension
5. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
6. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
7. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
8. The risk of myocardial infarction associated with antihypertensive drug therapies
9. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: Tuhe Nordic Diltiazem (NORDIL) study
10. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
11. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
12. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: Rationale, design, and methods
13. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension: Rationale and design